
eli lilly S&P 500
Eli Lilly and Company (LLY) is a global pharmaceutical company headquartered in Indianapolis, Indiana. The company focuses on the design, development and commercialization of prescription medicines and biologics. Its products are essential for the treatment of metabolic diseases, oncology, immunology and neuroscience, including therapies for diabetes and obesity as well as cancer and autoimmune conditions. Eli Lilly is a component of the S&P 500. The company plays a major role in the global pharmaceuticals sector and broader markets.
Start trading
Eli lilly now
At In2Markets, we offer unique strategies designed to align with your goals and adapt to changing market conditions. Our team will provide you with real-time support and expert insights to answer your question in a quick and personal way. Whether you’re trading or managing your portfolio, we combine innovation with a personalized approach to ensure you stay ahead.
